Gyntima Balance to prevent recurring bacterial vaginosis
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests whether a probiotic product called Gyntima Balance can help prevent bacterial vaginosis (BV)—a common vaginal infection—from coming back repeatedly. If it works, it could reduce uncomfortable symptoms and the need for repeated antibiotic treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female, between 18 and 45 years old, and not yet in menopause
- You have had at least 3 episodes of bacterial vaginosis in the past 12 months, with at least one confirmed in the last 6 months
- You currently have an active BV infection confirmed by a vaginal exam and lab tests (your doctor will check for specific signs like discharge appearance, clue cells under a microscope, a fishy odor, and vaginal pH level)
- You have not taken antibiotics or probiotics in the past 15 days, and are not using other vaginal products that kill bacteria
- You do not smoke, weigh within a healthy BMI range, and are willing to follow all study visits and procedures
- You do not have an IUD, untreated thyroid disease, uncontrolled diabetes or high blood pressure, HIV, other sexually transmitted infections, or other serious health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This study tests whether adding probiotics to standard care helps treat bacterial vaginosis (BV) and possibly lowers the chance of it coming back. You would be placed into a study group to compare probiotic treatment with the other approach.
This study tests a medical device called Vagitab-T as an extra treatment for women with bacterial vaginosis who are already taking the antibiotic metronidazole. It may help prevent the infection from coming back.
This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
This trial is testing a probiotic (friendly bacteria) treatment for postmenopausal women who have bacterial vaginosis. It aims to see if the probiotic can improve vaginal health.
Hear when a new Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.